Skip to main content
Top
Published in: Clinical & Experimental Metastasis 3/2000

01-05-2000

Inostamycin, an inhibitor of cytidine 5′-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): Inositol transferase, suppresses invasion ability by reducing productions of matrix metalloproteinase-2 and -9 and cell motility in HSC-4 tongue carcinoma cell line

Authors: Yuh Baba, Mamoru Tsukuda, Izumi Mochimatsu, Shigeru Furukawa, Hiroko Kagata, Yoji Nagashima, Naoki Sakai, Shinri Koshika, Masaya Imoto, Yasumasa Kato

Published in: Clinical & Experimental Metastasis | Issue 3/2000

Login to get access
Metadata
Title
Inostamycin, an inhibitor of cytidine 5′-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): Inositol transferase, suppresses invasion ability by reducing productions of matrix metalloproteinase-2 and -9 and cell motility in HSC-4 tongue carcinoma cell line
Authors
Yuh Baba
Mamoru Tsukuda
Izumi Mochimatsu
Shigeru Furukawa
Hiroko Kagata
Yoji Nagashima
Naoki Sakai
Shinri Koshika
Masaya Imoto
Yasumasa Kato
Publication date
01-05-2000
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 3/2000
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006798900743

Other articles of this Issue 3/2000

Clinical & Experimental Metastasis 3/2000 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine